An analysis of 83,219 chemotherapy patients revealed...¹⁷
GFR Testing May Occur Less Frequently
Than You Think

• Many of your chemotherapy patients may have iron deficiency anemia (IDA)


• Approximately 36% of adult chemotherapy patients had IDA^a (n=30,298)

• Among chemotherapy patients with IDA, glomerular filtration rate (GFR) was recorded less than half the time


• Fewer than 50% had a GFR value on record (n=14,283)


• It is important to consider absolute GFR values when reviewing lab reports, as different offices may use different levels to determine abnormal values. In some patients, a GFR <60 mL/min or GFR <90 mL/min may not be recorded as abnormal.

Adult chemotherapy patients with IDA who had their
GFR tested and recorded¹⁷


Source: ION, data from January 2008 to August 2010.¹⁷

CRI was prevalent in adult chemotherapy
patients with IDA^17,a,b

• Of the 14,283 patients with GFR values available, approximately 50% had GFR <60 mL/min (n=7089)


• 56% of patients with IDA and GFR <60 mL/min were not receiving IV iron therapy (n=3989)

Source: ION, data from January 2008 to August 2010.¹⁷

The National Kidney Foundation KDOQI™ Guidelines define CKD as kidney damage or GFR <60 mL/min for 3 months or more, with or without kidney damage.<sup>15

a</sup>IDA diagnosis based on patient coding: ICD-9-CM 280.1-9.

^bChronic renal insufficiency (CRI) and chronic kidney disease (CKD) refer to the same condition; terminology differs
among medical specialties.

IV=intravenous; KDOQI=National Kidney Foundation Kidney Disease Outcomes Quality Initiative.

KDOQI is a trademark of the National Kidney Foundation, Inc.

Now that you know about Cancer Patients With CRI, learn more about Iron Treatment.